BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15476157)

  • 41. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
    Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
    Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus.
    Jain A; DiMartini A; Kashyap R; Youk A; Rohal S; Fung J
    Transplantation; 2000 Nov; 70(9):1335-42. PubMed ID: 11087149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Tunissiolli NM; Castanhole-Nunes MMU; Pavarino ÉC; da Silva RF; da Silva RCMA; Maria Goloni-Bertollo E
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2795-2802. PubMed ID: 30360608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
    Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
    Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in liver transplantation for hepatitis C in a country with reduced access to direct-acting antiviral agents.
    Dirchwolf M; Marciano S; Giunta DH; Posadas-Martínez ML; Biggins SW; Ruf AE
    Clin Transplant; 2018 Apr; 32(4):e13230. PubMed ID: 29485711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
    Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
    J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.
    Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P
    Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term probability of and mortality from de novo malignancy after liver transplantation.
    Watt KD; Pedersen RA; Kremers WK; Heimbach JK; Sanchez W; Gores GJ
    Gastroenterology; 2009 Dec; 137(6):2010-7. PubMed ID: 19766646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
    Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
    Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication.
    Faure S; Herrero A; Jung B; Duny Y; Daures JP; Mura T; Assenat E; Bismuth M; Bouyabrine H; Donnadieu-Rigole H; Navarro F; Jaber S; Larrey D; Pageaux GP
    J Hepatol; 2012 Aug; 57(2):306-12. PubMed ID: 22521352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver transplantation in hepatitis C. A Spanish multi-centre experience.
    Prieto M; Berenguer M; Rimola A; Loinaz C; Barrios C; Clemente G; Figueras J; Vargas V; Casafont F; Pons JA; Herrero JI
    Eur J Gastroenterol Hepatol; 1998 Sep; 10(9):771-6. PubMed ID: 9831272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
    Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH
    Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide.
    Shah ND; Ventura-Cots M; Abraldes JG; Alboraie M; Alfadhli A; Argemi J; Badia-Aranda E; Arús-Soler E; Barritt AS; Bessone F; Biryukova M; Carrilho FJ; Fernández MC; Dorta Guiridi Z; El Kassas M; Eng-Kiong T; Queiroz Farias A; George J; Gui W; Thurairajah PH; Hsiang JC; Husić-Selimovic A; Isakov V; Karoney M; Kim W; Kluwe J; Kochhar R; Dhaka N; Costa PM; Nabeshima Pharm MA; Ono SK; Reis D; Rodil A; Domech CR; Sáez-Royuela F; Scheurich C; Siow W; Sivac-Burina N; Dos Santos Traquino ES; Some F; Spreckic S; Tan S; Vorobioff J; Wandera A; Wu P; Yacoub M; Yang L; Yu Y; Zahiragic N; Zhang C; Cortez-Pinto H; Bataller R
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2320-2329.e12. PubMed ID: 30708110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
    Yang JD; Larson JJ; Watt KD; Allen AM; Wiesner RH; Gores GJ; Roberts LR; Heimbach JA; Leise MD
    Clin Gastroenterol Hepatol; 2017 May; 15(5):767-775.e3. PubMed ID: 28013117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
    Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
    Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study.
    Singer AW; Reddy KR; Telep LE; Osinusi AO; Brainard DM; Buti M; Chokkalingam AP
    Aliment Pharmacol Ther; 2018 May; 47(9):1278-1287. PubMed ID: 29516535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation.
    Chirica M; Tranchart H; Tan V; Faron M; Balladur P; Paye F
    Ann Surg Oncol; 2013 Jul; 20(7):2405-12. PubMed ID: 23338483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
    Wong RJ; Aguilar M; Cheung R; Perumpail RB; Harrison SA; Younossi ZM; Ahmed A
    Gastroenterology; 2015 Mar; 148(3):547-55. PubMed ID: 25461851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.